Literature DB >> 1692153

The V delta gene usage by freshly isolated T lymphocytes from synovial fluids in rheumatoid synovitis: a preliminary report.

M Sioud1, J Kjeldsen-Kragh, A Quayle, C Kalvenes, K Waalen, O Førre, J B Natvig.   

Abstract

Taking advantage of the polymerase chain reaction we have studied the usage of variable delta-(V delta) region genes in freshly isolated synovial fluid T cells from patients with rheumatoid synovitis. Amplified mRNA from one patient with rheumatoid arthritis (RA) was cloned into an SmaI-cleaved pUC19 vector and colonies were screened with probes for three of the known human variable delta-gene families (V delta 1, V delta 2, V delta 3). Of 10 clones, seven used V delta 1, two V delta 2 and one V delta 3. This pattern of distribution is different from that of normal peripheral blood, where approximately 60% of T gamma delta cells are reported to use the V delta 2 gene. Furthermore, Northern blot hybridization analyses of mononuclear cells from two additional synovial fluids derived from another patient with RA and one with juvenile rheumatoid arthritis (JRA) also showed significant hybridization only with V delta 1. In summary, these preliminary results suggest a usage of V delta gene families in T gamma delta lymphocytes in synovial fluid of rheumatoid patients different to that found in normal peripheral blood.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1692153     DOI: 10.1111/j.1365-3083.1990.tb02787.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  9 in total

1.  Changes in human mucosal gamma delta T cell repertoire and function associated with the disease process in inflammatory bowel disease.

Authors:  L D McVay; B Li; R Biancaniello; M A Creighton; D Bachwich; G Lichtenstein; J L Rombeau; S R Carding
Journal:  Mol Med       Date:  1997-03       Impact factor: 6.354

2.  Increased serum and synovial fluid antibodies to immunoselected peptides in patients with rheumatoid arthritis.

Authors:  A Dybwad; O Førre; M Sioud
Journal:  Ann Rheum Dis       Date:  1996-07       Impact factor: 19.103

Review 3.  Role of heat shock proteins in protection from and pathogenesis of infectious diseases.

Authors:  U Zügel; S H Kaufmann
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

4.  The cytotoxic analysis of T cell receptor V delta 1+ T cell lines derived from the synovial fluid of rheumatoid arthritis patients.

Authors:  M Ohta; N Sato
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

5.  gammadelta T cells contribute to the systemic immunoglobulin E response and local B-cell reactivity in allergic eosinophilic airway inflammation.

Authors:  Linda Svensson; Bo Lilliehöök; Roland Larsson; Anders Bucht
Journal:  Immunology       Date:  2003-01       Impact factor: 7.397

6.  Analysis of gamma delta V region usage in normal and diseased human intestinal biopsies and peripheral blood by polymerase chain reaction (PCR) and flow cytometry.

Authors:  A Bucht; K Söderström; S Esin; J Grunewald; S Hagelberg; I Magnusson; H Wigzell; A Grönberg; R Kiessling
Journal:  Clin Exp Immunol       Date:  1995-01       Impact factor: 4.330

7.  A high proportion of the V delta 1+ synovial fluid gamma delta T cells in juvenile rheumatoid arthritis patients express the very early activation marker CD69, but carry the high molecular weight isoform of the leucocyte common antigen (CD45RA).

Authors:  J Kjeldsen-Kragh; A J Quayle; O Vinje; J B Natvig; O Førre
Journal:  Clin Exp Immunol       Date:  1993-02       Impact factor: 4.330

8.  Reduction in T gamma delta cell numbers and alteration in subset distribution in systemic lupus erythematosus.

Authors:  C Lunardi; C Marguerie; P Bowness; M J Walport; A K So
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

Review 9.  Integral Roles for Integrins in γδ T Cell Function.

Authors:  Gabrielle M Siegers
Journal:  Front Immunol       Date:  2018-03-13       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.